US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.41

-0.0300-0.68%

Volume:152.52K

Turnover:671.42K

Market Cap:259.90M

PE:-5.79

High:4.47

Open:4.41

Low:4.37

Close:4.44

Loading ...

Overview Company News Filings

FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate

Vanda Pharmaceuticals Highlights Issues in Gastroparesis Treatment Application Review in Letter to FDA Commissioner

MT Newswires Live

Vanda Pharmaceuticals: Issued Letter to FDA Regarding Sept. 18, 2024 Crl in Reference to Co's Nda for Tradipitant for Treatment of Gastroparesis

THOMSON REUTERS

Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis Nda Review

THOMSON REUTERS

Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review

RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded Use

Is it a Good Idea to Invest in Vanda Pharmaceuticals Stock Now?

KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates

The #1 growth stocks set to explode in 2025

3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying

Vanda Pharmaceuticals Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation

MT Newswires Live

Vanda Pharmaceuticals Gets FDA Orphan-Drug Designation for Cancer Treatment

Vanda Pharmaceuticals: Orphan Drug Designation Granted for VGT-1849A

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for Vgt-1849a, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

THOMSON REUTERS

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

Vanda Pharmaceuticals treatment of polycythemia vera granted orphan status

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VNDA/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VNDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","market":"US","secType":"STK","nameCN":"Vanda Pharmaceuticals","latestPrice":4.41,"timestamp":1747843108242,"preClose":4.44,"halted":0,"volume":152521,"delay":0,"floatShares":53360429,"shares":58934482,"eps":-0.761213,"marketStatus":"Trading","change":-0.03,"latestTime":"05-21 12:00:06 EDT","open":4.41,"high":4.47,"low":4.37,"amount":671419.3287635001,"amplitude":0.022523,"askPrice":4.4,"askSize":1000,"bidPrice":4.39,"bidSize":106,"shortable":3,"etf":0,"ttmEps":-0.761213,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747857600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1144814400000,"exchange":"NASDAQ","adjPreClose":4.44,"preHourTrading":{"tag":"盘前","latestPrice":4.34,"preClose":4.44,"latestTime":"09:16 EDT","volume":25,"amount":108.5,"timestamp":1747833405565},"postHourTrading":{"tag":"盘后","latestPrice":4.44,"preClose":4.44,"latestTime":"18:58 EDT","volume":5113,"amount":22933.7634,"timestamp":1747781930665},"volumeRatio":0.564225,"impliedVol":0.0222,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","floatShares":53360429,"roa":"-7.05%","roe":"-8.38%","lyrEps":-0.325026,"volumeRatio":0.564225,"shares":58934482,"dividePrice":0,"high":4.47,"amplitude":0.022523,"preClose":4.44,"low":4.37,"week52Low":3.8092,"pbRate":"0.51","psRate":"1.29","week52High":6.75,"institutionHeld":0.7045,"latestPrice":4.41,"committee":-0.808318,"eps":-0.761213,"divideRate":0,"volume":152521,"delay":0,"ttmEps":-0.761213,"open":4.41,"prevYearClose":4.79,"prevWeekClose":4.16,"prevMonthClose":4.51,"prevQuarterClose":4.59,"fiveDayClose":3.92,"twentyDayClose":4.33,"sixtyDayClose":4.46},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VNDA\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2504498919","title":"FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2504498919","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504498919?lang=en_us&edition=fundamental","pubTime":"2025-01-17 02:47","pubTimestamp":1737053254,"startTime":"0","endTime":"0","summary":"The Director of the Center for Drug Evaluation and Research  at the U.S. Food and Drug Administration  issued a notice summarizing the grounds for refusing a new drug application  submitted by Vanda Pharmaceuticals, Inc.  for Tradipitant for symptoms in gastroparesis.The notice offers Vanda an opportunity to request a hearing on the matter.Also Read: Over 200% Stock Upside – Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst. In September, the FDA issued a Complete Response Letter to the company. The agency disregarded the evidence provided and instead suggested that Vanda conduct additional studies with a design and duration inconsistent with the advice of key experts in the field and not appropriate based on the scientific understanding and natural course of the disorder.Last week, Vanda Pharmaceuticals wrote a letter to the FDA Commissioner highlighting faulty gastroparesis NDA review.In the 3301 Phase 3 Study , the drug did not show a statistically signif","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-unveils-grounds-rejecting-vanda-184734054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2502829350","title":"Vanda Pharmaceuticals Highlights Issues in Gastroparesis Treatment Application Review in Letter to FDA Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2502829350","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502829350?lang=en_us&edition=fundamental","pubTime":"2025-01-09 07:09","pubTimestamp":1736377745,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (VNDA) said late Wednesday it sent a letter to US Food and Drug Administration Commissioner Robert Califf, highlighting what it described as the agency's \"faulty\" review of the c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2502425083","title":"Vanda Pharmaceuticals: Issued Letter to FDA Regarding Sept. 18, 2024 Crl in Reference to Co's Nda for Tradipitant for Treatment of Gastroparesis","url":"https://stock-news.laohu8.com/highlight/detail?id=2502425083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502425083?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:17","pubTimestamp":1736371066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA8FMHGS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2502083190","title":"Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis Nda Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083190","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083190?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:17","pubTimestamp":1736371066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA8FMHGS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2502308558","title":"Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2502308558","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502308558?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:17","pubTimestamp":1736371020,"startTime":"0","endTime":"0","summary":"WASHINGTON, Jan. 8, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   letter to FDA Commissioner highlights faulty gastroparesis NDA review.As previously reported, Vanda has sought approval from the U.S. Food and Drug Administration  for tradipitant for the treatment of patients with gastroparesis. FDA declined to approve Vanda's New Drug Application  for tradipitant for the treatment of symptoms of gastroparesis, providing Vanda with a Complete Response Letter  on September 18, 2024.Today, Vanda issued a letter to FDA Commissioner Robert M. Califf, MD, regarding the September 18, 2024 CRL in reference to Vanda's NDA for tradipitant for the treatment of gastroparesis. The full letter is shown below:. In addition, FDA has denied our request to convene an Advisory Committee to consider our application for tradipitant, a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/vandas-letter-fda-commissioner-highlights-211700674.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vandas-letter-fda-commissioner-highlights-211700674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CRL","BK4588","LU0390134368.USD","BK4121","VNDA","BK4530","BK4585"],"gpt_icon":0},{"id":"2501780966","title":"RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2501780966","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501780966?lang=en_us&edition=fundamental","pubTime":"2025-01-07 23:14","pubTimestamp":1736262840,"startTime":"0","endTime":"0","summary":"HOFH is an inherited disease that causes dangerously high levels of low-density lipoprotein cholesterol , or bad cholesterol. It affects approximately 1,600 people in the EU and 1 in 300,000 globally. Please note that Evkeeza was initially approved in the EU in 2021 as an adjunct to diet and other LDL-C-lowering therapies to treat adult and adolescent patients aged 12 years and older with HoFH. The drug’s label was later expanded in 2023 to include the treatment of children aged 5-11 years old with HoFH. The drug is also approved in multiple other geographies for the HoFH indication like the United States, United Kingdom and Canada, among others.In the past three months, shares of Ultragenyx have plunged 20% compared with the industry’s 9.4% decline.More on Evkeeza’s Label Update for Younger HoFH Patients. Ultragenyx’s commercial portfolio comprises three other medicines — Mepsevii , Crysvita  and Dojolvi .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rares-cholesterol-drug-evkeeza-gains-151400355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","BK4196","LU1974910355.USD","LU0882574055.USD","LU0823416689.USD","LU0114720955.EUR","LU2106854487.HKD","BK4588","LU2468319806.SGD","VNDA","LU0889565916.HKD","EC","LU2023250504.SGD","BK4139","BK4585","LU2362541273.HKD","LU2089984988.USD","CSTL","LU2362540622.SGD","LU0289739699.SGD","LU0058720904.USD","BK4201","RARE","REGN","LU2362541513.USD","LU1917777945.USD","LU2237438978.USD","LU0053666078.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2501662462","title":"Is it a Good Idea to Invest in Vanda Pharmaceuticals Stock Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2501662462","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501662462?lang=en_us&edition=fundamental","pubTime":"2025-01-07 00:54","pubTimestamp":1736182440,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc. VNDA generates revenues from the sale of its three commercial products, Fanapt, Hetlioz and Ponvory.Fanapt is approved in the United States for two indications, schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder. Hetlioz is approved to treat non-24-hour sleep-wake disorder and nighttime sleep disturbances in Smith-Magenis syndrome.Ponvory is an oral treatment approved to treat relapsing forms of multiple sclerosis. VNDA acquired the United States and Canada rights to Ponvory from Actelion Pharmaceuticals Limited, a subsidiary of Johnson & Johnson JNJ, in December 2023.JNJ gained approval for Ponvory as an oral treatment for adults with relapsing forms of multiple sclerosis in 2021.In the past year, shares of Vanda have gained 13.9% against the industry’s decline of 16%.In the past 60 days, estimates for Puma Biotechnology’s 2025 earnings per share have increased from 42 cents to 54 cents. In the past year, shares o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/good-idea-invest-vanda-pharmaceuticals-165400674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0640476718.USD","LU0320765646.SGD","LU0792757196.USD","LU1032466523.USD","LU1261432733.SGD","LU0234572021.USD","LU0345769631.USD","JNJ","IE00B3PB1722.GBP","BK4007","LU0058720904.USD","IE0002270589.USD","LU0882574055.USD","LU0122379950.USD","ASO","LU1196500208.SGD","IE00BSNM7G36.USD","LU2089984988.USD","BK4533","CSTL","IE00BVYPNV92.GBP","LU1066051811.HKD","SG9999001440.SGD","LU1059921491.USD","LU1074936037.SGD","IE000M9KFDE8.USD","LU1430594728.SGD","LU1914381329.SGD","BK4581","IE00BJJMRZ35.SGD","LU1718418525.SGD","BK4592","LU0203345920.USD","LU0889566641.SGD","LU1221951046.USD","LU1506573853.SGD","LU1674673428.USD","LU1057294990.SGD","LU0466842654.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","PBYI","LU1732799900.SGD","LU0795875086.SGD","LU1929549753.HKD","IE00B1BXHZ80.USD","VNDA","LU2468319806.SGD","BK4568"],"gpt_icon":0},{"id":"2501025191","title":"KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2501025191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501025191?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:59","pubTimestamp":1736171940,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences KOD have skyrocketed 270.7% in the past six months fueled by updates from the developmental program of its lead investigational candidate, tarcocimab. It is a novel anti-VEGF antibody biopolymer conjugate, which is being evaluated for treating retinal vascular diseases.In late 2023, Kodiak rebooted the development program of tarcocimab following positive phase III results from the GLOW1 study, which evaluated the treatment in patients with moderately severe to severe non-proliferative diabetic retinopathy. Leveraging the GLOW1 study's success, Kodiak initiated the GLOW2 study in late 2023 to further investigate tarcocimab for diabetic retinopathy  and began dosing patients in May 2024, with enrollment expected to be completed soon. The success of the GLOW2 study is expected to serve as the basis for a single biologics license application submission for tarcocimab, seeking its approval for DR.The revival of tarcocimab in Kodiak's pipeline, after a major setback","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kod-stock-rallies-271-6-135900100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VNDA","BK4196","BK4139","CSTL","BK4505","KOD","CTMX"],"gpt_icon":0},{"id":"2501449276","title":"The #1 growth stocks set to explode in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501449276","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501449276?lang=en_us&edition=fundamental","pubTime":"2025-01-06 04:00","pubTimestamp":1736107237,"startTime":"0","endTime":"0","summary":"You can watch the video by clicking the player, listen to the podcast, or read an edited transcript below. These interviews were filmed on Tuesday, 10 December 2023.The name Thomas Rowe Price Junior should have been consigned to the investing scrap heap.Born in 1898, Price’s career was just hitting its stride as the Great Depression hit and hit hard. At the time, he was the head of investment for the broking firm MacKubin, Legg and Co., but instead of developing great hate for markets, he fell even more in love with them.That inspired him to start T. Rowe Price and Associates in 1937, with a then-revolutionary focus on growth investing.His guiding philosophy was that by investing in well-managed companies operating in deep pools of opportunity, he could generate returns ahead of inflation and the overall economy.It’s a philosophy that would earn Price the moniker the “Father of growth investing”. T. Rowe Price still operates to this day and manages around US$1.6 trillion globally.Proba","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/the-1-growth-stocks-set-to-explode-in-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/the-1-growth-stocks-set-to-explode-in-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["DGT.AU","PGC.AU","VNDA","LU0572944931.SGD","LU0228659784.USD","BK4526","LU0417516902.SGD","LU0594300419.USD","LU0737861772.HKD","ZIP.AU","BK7007","QOR.AU","BK4534","LU2152927971.USD","SIG.AU","LU0650527681.SGD","LU0048580855.USD","BK4142","BK7095","CORZ","LU0359202008.SGD","CYC.AU","LU0359201612.USD","360.AU","LU0561508036.HKD","BOE.AU","NXT.AU","BK4139","LU0828237510.HKD","IE00BPRC5H50.USD","ARR.AU","BK4585","LU2399975544.HKD","LU1961090484.USD","IE00B0JY6N72.USD","TCOM","LU0359201885.HKD","LU0593848301.USD","ARR","LU0348825331.USD","TNE.AU","BK7166","IE00B5MMRT66.SGD","BK7043","LU1023057109.AUD","BK4116","LU0370786039.SGD","LU0143863784.USD"],"gpt_icon":0},{"id":"2493082439","title":"3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2493082439","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493082439?lang=en_us&edition=fundamental","pubTime":"2024-12-24 20:47","pubTimestamp":1735044420,"startTime":"0","endTime":"0","summary":"The year 2024 has been a mixed ride for the biotech industry. It started on a positive note, attracting investors’ attention in areas with great commercial potential, like obesity, immunology and gene therapy.However, their interest started to wane in the second half of the year amid lower-than-expected third-quarter results, guidance cuts and pipeline setbacks. While Wall Street viewed Trump’s victory as an accelerant for M&A activity in the sector, the President-elect’s decision to nominate vaccine skeptic Robert F. Kennedy Jr. to run the Department of Health and Human Services concerned investors in biotech stocks. These factors have negatively impacted nearly all companies in the industry. Year to date, the biotech sector has declined nearly 14%.Investing in low-priced stocks with the potential for a healthy return is a good idea. One of the safest options to capitalize on money-making opportunities is following Wall Street recommendations and their experts’ advice.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/X_G78K7TS0Wks9k_NbYhwg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/X_G78K7TS0Wks9k_NbYhwg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-under-10-drug-stocks-124700943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4110","LU2125154778.USD","ABR","RZLT","VNDA","ALLO","LU2125154935.USD","BK4505","HI","BK4139","LU0128526141.USD","LU0029874061.USD","BK4161","LU2360032135.SGD"],"gpt_icon":0},{"id":"2493756247","title":"Vanda Pharmaceuticals Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2493756247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493756247?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:01","pubTimestamp":1734955260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VNDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 23, 2024 07:01 ET (12:01 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA"],"gpt_icon":0},{"id":"2492842834","title":"Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2492842834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492842834?lang=en_us&edition=fundamental","pubTime":"2024-12-20 23:47","pubTimestamp":1734709642,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals  said Friday morning that the US Food and Drug Administration has designated the company's VGT-1849A product candidate as an orphan drug to treat polycythemia vera, a rare form of hematologic malignancy affecting about one in every 2,000 people in the country.The FDA uses orphan drug designation to incentivize the development of prospective treatments for conditions affecting relatively few people. Therapies receiving the designation are eligible for selected tax credits and exemption from certain fees and up to seven years of market exclusivity following regulatory approval.Vanda shares recently were up 1.5% during Friday morning trade.Price: 4.70, Change: +0.07, Percent Change: +1.51","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2492944129","title":"Vanda Pharmaceuticals Gets FDA Orphan-Drug Designation for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2492944129","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492944129?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:37","pubTimestamp":1734705420,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals said the Food and Drug Administration has granted orphan-drug designation for VGT-1849A.VGT-1849A is a selective antisense oligonucleotide-based JAK2 inhibitor for the treatment of polycythemia vera, a form of a rare hematologic malignancy.The biopharmaceutical company said ASO VGT-1849A has the potential to reduce JAK2V617F-driven pathogenic signaling, ultimately suppressing the malignant proliferation and survival of hematopoietic cells.By specifically targeting JAK2, the Washington, D.C., company hopes to reduce the risk of infection and toxic effects that are seen with inhibitors also blocking JAK1, JAK3, TYK2, or other kinases outside of the JAK family.If approved, Vanda said VGT-1849A could offer targeted efficacy with an improved safety profile and convenient dosing.Orphan-drug designation is granted by the FDA to investigational therapies addressing rare medical conditions and provides benefits to drug developers.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2492443034","title":"Vanda Pharmaceuticals: Orphan Drug Designation Granted for VGT-1849A","url":"https://stock-news.laohu8.com/highlight/detail?id=2492443034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492443034?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:25","pubTimestamp":1734704743,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (VNDA) announced the U.S. FDA has granted Orphan Drug Designation for VGT-1849A, a selective antisense oligonucleotide-based ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vanda-pharmaceuticals-orphan-drug-designation-granted-for-vgt-1849a?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vanda-pharmaceuticals-orphan-drug-designation-granted-for-vgt-1849a?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","VGT","BK4585","BK4139","VNDA"],"gpt_icon":0},{"id":"2492449559","title":"Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for Vgt-1849a, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2492449559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492449559?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:13","pubTimestamp":1734704030,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUA3LV5WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2493842824","title":"Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2493842824","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493842824?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:13","pubTimestamp":1734703980,"startTime":"0","endTime":"0","summary":"WASHINGTON, Dec. 20, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced the U.S. Food and Drug Administration  has granted Orphan Drug Designation for VGT-1849A, a selective antisense oligonucleotide -based JAK2 inhibitor for the treatment of polycythemia vera , a form of a rare hematologic malignancy that is estimated to affect 1 in 2000 Americans.1. \"This orphan designation for VGT-1849A is an important milestone in precision medicine-based therapeutics in the space of hematological malignancies. This milestone marks the second precision medicine therapeutic for Vanda following the development of VCA-894A for Charcot-Marie-Tooth3 that is expected to begin clinical testing in the coming months,\" said Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GoZtN2oA0dsLtPL6WN74tg--~B/aD05MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/18f330ec7ac238d1fe3f7d2754fbd531","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GoZtN2oA0dsLtPL6WN74tg--~B/aD05MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/18f330ec7ac238d1fe3f7d2754fbd531"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announces-orphan-drug-141300802.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announces-orphan-drug-141300802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4588","VGT","ASO","VNDA","BK4139","BK4200","BK4561"],"gpt_icon":0},{"id":"2492441876","title":"Exploring Three High Growth Tech Stocks In The United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2492441876","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492441876?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:06","pubTimestamp":1734703573,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a 3.5% drop, yet it has shown resilience with a 22% rise over the past year and an anticipated annual earnings growth of 15%. In this dynamic environment, identifying high-growth tech stocks involves assessing their potential to capitalize on technological advancements and market trends while aligning with robust growth forecasts.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 237 stocks from our US High Growth Tech and AI Stocks screener.Overview: aTyr Pharma, Inc. is a biotherapeutics company focused on discovering and developing medicines targeting novel immunological pathways in the United States, with a market capitalization of $264.42 million.Overview: Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for high unmet medical needs globally, with a market capitalization of approximately $265.30 million.Operations: Va","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-three-high-growth-tech-140613251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KNSA","ATYR","BK4211","VNDA","UBCP","BK4139"],"gpt_icon":1},{"id":"2492485231","title":"Vanda Pharmaceuticals treatment of polycythemia vera granted orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2492485231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492485231?lang=en_us&edition=fundamental","pubTime":"2024-12-20 04:00","pubTimestamp":1734638421,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (VNDA)’ treatment of polycythemia vera was granted FDA orphan designation, according to a post to the agency’s website. Publi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vanda-pharmaceuticals-treatment-of-polycythemia-vera-granted-orphan-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vanda-pharmaceuticals-treatment-of-polycythemia-vera-granted-orphan-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VNDA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":78,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VNDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"VNDA","fiscalQuarterEnding":"2025/03","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.5},{"market":"US","date":"2025-02-13","symbol":"VNDA","fiscalQuarterEnding":"2024/12","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-11-06","symbol":"VNDA","fiscalQuarterEnding":"2024/09","expectedEps":-0.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2024-07-31","symbol":"VNDA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-05-08","symbol":"VNDA","fiscalQuarterEnding":"2024/03","expectedEps":0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VNDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VNDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1730433600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VNDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VNDA","date":"2025-05-19","current":-5.540758,"percent":0.192721,"low":-77.375491,"twenty":4.491594,"median":26.113076,"eighty":50.47466,"high":127.111916,"avg":24.369796,"sd":34.897003,"marketCap":245167445},"quantilePoints":[{"date":"2020-05-22","current":5.317046,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":620238741},{"date":"2020-05-29","current":5.480719,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":639331402},{"date":"2020-06-05","current":5.359134,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":625148283},{"date":"2020-06-12","current":4.989699,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":582053418},{"date":"2020-06-19","current":5.214166,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":608237640},{"date":"2020-06-26","current":5.214166,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":608237640},{"date":"2020-07-02","current":5.541512,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":646422962},{"date":"2020-07-10","current":5.373163,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":626784796},{"date":"2020-07-17","current":5.228195,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":609874153},{"date":"2020-07-24","current":4.952288,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":577689381},{"date":"2020-07-31","current":4.713793,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":549868646},{"date":"2020-08-07","current":5.760915,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":655816788},{"date":"2020-08-14","current":5.60249,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":637781826},{"date":"2020-08-21","current":5.117613,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":582583913},{"date":"2020-08-28","current":4.971189,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":565915236},{"date":"2020-09-04","current":4.925582,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":560723353},{"date":"2020-09-11","current":4.675943,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":532304626},{"date":"2020-09-18","current":4.728751,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":538316280},{"date":"2020-09-25","current":4.474311,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":509351038},{"date":"2020-10-02","current":4.690345,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":533944168},{"date":"2020-10-09","current":5.266436,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":599525847},{"date":"2020-10-16","current":5.180023,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":589688595},{"date":"2020-10-23","current":4.920781,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":560176839},{"date":"2020-10-30","current":30.19438,"twenty":-17.144215,"median":5.899218,"eighty":29.694964,"marketCap":584653781},{"date":"2020-11-06","current":33.117784,"twenty":-17.144215,"median":6.154515,"eighty":30.889744,"marketCap":641259643},{"date":"2020-11-13","current":37.19925,"twenty":-17.144215,"median":6.554443,"eighty":31.992923,"marketCap":720289083},{"date":"2020-11-20","current":34.911369,"twenty":-17.144215,"median":6.62676,"eighty":32.919643,"marketCap":675988843},{"date":"2020-11-27","current":35.052596,"twenty":-17.144215,"median":6.775773,"eighty":33.264042,"marketCap":678723426},{"date":"2020-12-04","current":37.707668,"twenty":-17.144215,"median":6.845898,"eighty":33.583841,"marketCap":730133580},{"date":"2020-12-11","current":36.083555,"twenty":-17.144215,"median":7.118726,"eighty":34.102745,"marketCap":698685879},{"date":"2020-12-18","current":39.006959,"twenty":-17.144215,"median":7.203095,"eighty":34.28248,"marketCap":755291741},{"date":"2020-12-24","current":37.50995,"twenty":-17.144215,"median":7.30609,"eighty":34.52533,"marketCap":726305165},{"date":"2020-12-31","current":37.114514,"twenty":-17.144215,"median":7.332386,"eighty":34.679035,"marketCap":718648333},{"date":"2021-01-08","current":38.978713,"twenty":-17.144215,"median":7.417851,"eighty":34.913039,"marketCap":754744825},{"date":"2021-01-15","current":38.780995,"twenty":-17.144215,"median":7.501124,"eighty":35.145052,"marketCap":750916409},{"date":"2021-01-22","current":40.108531,"twenty":-17.144215,"median":7.631511,"eighty":35.920836,"marketCap":776621486},{"date":"2021-01-29","current":40.503967,"twenty":-17.144215,"median":9.691848,"eighty":36.113637,"marketCap":784278318},{"date":"2021-02-05","current":42.820094,"twenty":-17.144215,"median":9.973445,"eighty":36.379702,"marketCap":829125474},{"date":"2021-02-12","current":42.87234,"twenty":-17.144215,"median":10.161149,"eighty":36.651009,"marketCap":1000511803},{"date":"2021-02-19","current":43.977661,"twenty":-17.144215,"median":10.195815,"eighty":36.786867,"marketCap":1026306677},{"date":"2021-02-26","current":43.860074,"twenty":-17.144215,"median":10.351377,"eighty":36.95069,"marketCap":1023562541},{"date":"2021-03-05","current":42.907616,"twenty":-17.154068,"median":10.647105,"eighty":37.165355,"marketCap":1001335043},{"date":"2021-03-12","current":42.119781,"twenty":-17.154068,"median":11.30316,"eighty":37.398806,"marketCap":982949336},{"date":"2021-03-19","current":41.085013,"twenty":-17.154068,"median":11.789039,"eighty":37.50995,"marketCap":958800943},{"date":"2021-03-26","current":36.38152,"twenty":-17.144215,"median":12.283231,"eighty":37.538196,"marketCap":849035523},{"date":"2021-04-01","current":36.945939,"twenty":-17.144215,"median":12.510069,"eighty":37.538196,"marketCap":862207374},{"date":"2021-04-09","current":38.215882,"twenty":-17.154068,"median":12.594144,"eighty":37.651054,"marketCap":891844037},{"date":"2021-04-16","current":39.203616,"twenty":-17.154068,"median":12.774882,"eighty":37.912898,"marketCap":914894775},{"date":"2021-04-23","current":40.403255,"twenty":-17.154068,"median":12.824175,"eighty":38.140123,"marketCap":942890771},{"date":"2021-04-30","current":39.522336,"twenty":-17.154068,"median":12.914543,"eighty":38.320951,"marketCap":922332752},{"date":"2021-05-07","current":31.503027,"twenty":-17.154068,"median":12.991494,"eighty":38.326403,"marketCap":992376862},{"date":"2021-05-14","current":32.896498,"twenty":-17.154068,"median":13.029375,"eighty":38.326403,"marketCap":1036272591},{"date":"2021-05-21","current":32.614276,"twenty":-17.154068,"median":13.095281,"eighty":38.326403,"marketCap":1027382316},{"date":"2021-05-28","current":31.203166,"twenty":-17.154068,"median":13.194903,"eighty":38.326403,"marketCap":982930945},{"date":"2021-06-04","current":31.92636,"twenty":-17.154068,"median":13.218512,"eighty":38.326403,"marketCap":1005712273},{"date":"2021-06-11","current":33.831358,"twenty":-17.154068,"median":13.226727,"eighty":38.326403,"marketCap":1065721624},{"date":"2021-06-18","current":33.81372,"twenty":-17.154068,"median":13.259589,"eighty":38.326403,"marketCap":1065165982},{"date":"2021-06-25","current":36.653578,"twenty":-17.154068,"median":13.335965,"eighty":38.326403,"marketCap":1154624366},{"date":"2021-07-02","current":36.724134,"twenty":-17.154068,"median":13.357957,"eighty":38.326403,"marketCap":1156846935},{"date":"2021-07-09","current":36.194967,"twenty":-17.154068,"median":13.357957,"eighty":38.326403,"marketCap":1140177671},{"date":"2021-07-16","current":33.390387,"twenty":-17.154068,"median":13.385175,"eighty":38.326403,"marketCap":1051830571},{"date":"2021-07-23","current":34.642747,"twenty":-17.154068,"median":13.434386,"eighty":38.326403,"marketCap":1091281162},{"date":"2021-07-30","current":27.973443,"twenty":-17.154068,"median":13.483596,"eighty":38.326403,"marketCap":907458487},{"date":"2021-08-06","current":27.441759,"twenty":-17.154068,"median":13.631226,"eighty":38.326403,"marketCap":890210656},{"date":"2021-08-13","current":28.24786,"twenty":-17.154068,"median":13.670356,"eighty":38.326403,"marketCap":916360594},{"date":"2021-08-20","current":27.115888,"twenty":-17.154068,"median":13.75522,"eighty":38.326403,"marketCap":879639404},{"date":"2021-08-27","current":29.6371,"twenty":-17.154068,"median":13.826448,"eighty":38.326403,"marketCap":961427508},{"date":"2021-09-03","current":28.71094,"twenty":-17.154068,"median":13.854535,"eighty":38.326403,"marketCap":931382898},{"date":"2021-09-10","current":27.76763,"twenty":-17.154068,"median":13.953851,"eighty":38.326403,"marketCap":900781907},{"date":"2021-09-17","current":29.071113,"twenty":-17.154068,"median":14.053167,"eighty":38.326403,"marketCap":943066913},{"date":"2021-09-24","current":29.602797,"twenty":-17.154068,"median":14.081124,"eighty":38.326403,"marketCap":960314745},{"date":"2021-10-01","current":30.494654,"twenty":-17.154068,"median":14.152482,"eighty":38.326403,"marketCap":989246591},{"date":"2021-10-08","current":31.026339,"twenty":-17.154068,"median":14.270959,"eighty":38.326403,"marketCap":1006494422},{"date":"2021-10-15","current":31.575174,"twenty":-17.154068,"median":14.301456,"eighty":38.326403,"marketCap":1024298636},{"date":"2021-10-22","current":31.386512,"twenty":-17.154068,"median":14.351114,"eighty":38.326403,"marketCap":1018178437},{"date":"2021-10-29","current":29.362682,"twenty":-17.154068,"median":14.4678,"eighty":38.326403,"marketCap":952525401},{"date":"2021-11-05","current":29.12112,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":997806039},{"date":"2021-11-12","current":28.877224,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":989449204},{"date":"2021-11-19","current":27.576448,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":944879420},{"date":"2021-11-26","current":26.909801,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":922037406},{"date":"2021-12-03","current":26.373231,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":903652370},{"date":"2021-12-10","current":25.706583,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":880810356},{"date":"2021-12-17","current":27.153696,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":930394241},{"date":"2021-12-23","current":29.234937,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":1001705895},{"date":"2021-12-31","current":25.511466,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":874124888},{"date":"2022-01-07","current":25.007416,"twenty":-17.144215,"median":14.807432,"eighty":38.3263,"marketCap":856854097},{"date":"2022-01-14","current":24.389547,"twenty":-17.144215,"median":14.956751,"eighty":38.3263,"marketCap":835683450},{"date":"2022-01-21","current":23.072512,"twenty":-17.144215,"median":18.908459,"eighty":38.3263,"marketCap":790556543},{"date":"2022-01-28","current":23.966795,"twenty":-17.144215,"median":23.183837,"eighty":38.3263,"marketCap":821198270},{"date":"2022-02-04","current":19.560417,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":670218126},{"date":"2022-02-11","current":21.983112,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":753229349},{"date":"2022-02-18","current":21.804255,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":747101004},{"date":"2022-02-25","current":18.853723,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":625038638},{"date":"2022-03-04","current":18.280354,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":606030308},{"date":"2022-03-11","current":18.786268,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":622802364},{"date":"2022-03-18","current":20.287146,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":672559465},{"date":"2022-03-25","current":19.32591,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":640692558},{"date":"2022-04-01","current":19.94987,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":661378094},{"date":"2022-04-08","current":19.916143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":660259957},{"date":"2022-04-14","current":19.157272,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":635101872},{"date":"2022-04-22","current":18.448992,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":611620993},{"date":"2022-04-29","current":16.903143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":560372983},{"date":"2022-05-06","current":30.007815,"twenty":-17.144215,"median":23.81234,"eighty":38.3263,"marketCap":542301235},{"date":"2022-05-13","current":31.289399,"twenty":-17.144215,"median":23.974925,"eighty":38.3263,"marketCap":565462017},{"date":"2022-05-20","current":31.008076,"twenty":-17.144215,"median":24.499553,"eighty":38.3263,"marketCap":560377943},{"date":"2022-05-27","current":31.94582,"twenty":-17.144215,"median":24.726466,"eighty":38.3263,"marketCap":577324856},{"date":"2022-06-03","current":31.727013,"twenty":-17.144215,"median":24.881125,"eighty":38.3263,"marketCap":573370576},{"date":"2022-06-10","current":30.539204,"twenty":-17.144215,"median":25.073094,"eighty":38.3263,"marketCap":551904486},{"date":"2022-06-17","current":29.914041,"twenty":-17.144215,"median":25.293157,"eighty":38.3263,"marketCap":540606543},{"date":"2022-06-24","current":33.446211,"twenty":-17.154068,"median":25.452351,"eighty":38.326403,"marketCap":604439918},{"date":"2022-07-01","current":34.97786,"twenty":-17.101725,"median":25.564724,"eighty":38.326403,"marketCap":632119877},{"date":"2022-07-08","current":36.759574,"twenty":-17.02494,"median":25.639639,"eighty":38.326403,"marketCap":664319013},{"date":"2022-07-15","current":35.853087,"twenty":-16.800559,"median":25.706583,"eighty":38.326403,"marketCap":647936996},{"date":"2022-07-22","current":34.29018,"twenty":-16.579017,"median":26.014214,"eighty":38.326403,"marketCap":619692140},{"date":"2022-07-29","current":33.696276,"twenty":-15.600428,"median":26.267051,"eighty":38.326403,"marketCap":608959095},{"date":"2022-08-05","current":54.282127,"twenty":3.791287,"median":26.340711,"eighty":38.356987,"marketCap":596723424},{"date":"2022-08-12","current":53.561796,"twenty":4.32242,"median":26.426246,"eighty":38.538084,"marketCap":588804819},{"date":"2022-08-19","current":53.253082,"twenty":4.487703,"median":26.576076,"eighty":38.789104,"marketCap":585411131},{"date":"2022-08-26","current":52.73856,"twenty":4.580888,"median":26.909801,"eighty":38.878336,"marketCap":579754985},{"date":"2022-09-02","current":53.407439,"twenty":4.668262,"median":27.104917,"eighty":38.971271,"marketCap":587107975},{"date":"2022-09-09","current":52.944369,"twenty":4.722768,"median":27.300033,"eighty":39.099148,"marketCap":582017443},{"date":"2022-09-16","current":51.246444,"twenty":4.761973,"median":27.45891,"eighty":39.345148,"marketCap":563352161},{"date":"2022-09-23","current":49.754329,"twenty":4.810183,"median":27.630421,"eighty":39.443307,"marketCap":546949337},{"date":"2022-09-30","current":50.834826,"twenty":4.836812,"median":27.76763,"eighty":39.543622,"marketCap":558827244},{"date":"2022-10-07","current":50.783374,"twenty":4.921115,"median":27.924545,"eighty":39.763436,"marketCap":558261629},{"date":"2022-10-14","current":50.47466,"twenty":4.941755,"median":28.024896,"eighty":39.984463,"marketCap":554867942},{"date":"2022-10-21","current":53.355987,"twenty":4.983255,"median":28.178057,"eighty":40.08767,"marketCap":586542360},{"date":"2022-10-28","current":54.590841,"twenty":5.012956,"median":28.291875,"eighty":40.302998,"marketCap":600117111},{"date":"2022-11-04","current":91.788849,"twenty":5.062961,"median":28.448949,"eighty":40.563626,"marketCap":595893205},{"date":"2022-11-11","current":93.27072,"twenty":5.093819,"median":28.590882,"eighty":40.972842,"marketCap":605513513},{"date":"2022-11-18","current":93.096382,"twenty":5.117101,"median":28.71094,"eighty":41.160269,"marketCap":604381712},{"date":"2022-11-25","current":90.91716,"twenty":5.138736,"median":28.748609,"eighty":41.266594,"marketCap":590234200},{"date":"2022-12-02","current":95.101267,"twenty":5.157046,"median":28.985358,"eighty":41.937708,"marketCap":617397423},{"date":"2022-12-09","current":91.614511,"twenty":5.176833,"median":29.071113,"eighty":42.119781,"marketCap":594761404},{"date":"2022-12-16","current":61.454072,"twenty":5.208554,"median":29.234937,"eighty":42.368145,"marketCap":398959838},{"date":"2022-12-23","current":59.885032,"twenty":5.239077,"median":29.511352,"eighty":43.046766,"marketCap":388773629},{"date":"2022-12-30","current":64.417815,"twenty":5.255617,"median":29.543872,"eighty":43.602452,"marketCap":418200454},{"date":"2023-01-06","current":64.679322,"twenty":5.277282,"median":29.6371,"eighty":43.9356,"marketCap":419898156},{"date":"2023-01-13","current":66.858544,"twenty":5.292197,"median":30.070331,"eighty":44.079494,"marketCap":434045668},{"date":"2023-01-20","current":65.725348,"twenty":5.315176,"median":30.184129,"eighty":48.044423,"marketCap":426688961},{"date":"2023-01-27","current":66.684206,"twenty":5.339308,"median":30.476687,"eighty":49.929267,"marketCap":432913867},{"date":"2023-02-03","current":66.684206,"twenty":5.359134,"median":30.528529,"eighty":50.515822,"marketCap":432913867},{"date":"2023-02-10","current":65.789461,"twenty":5.371292,"median":30.60172,"eighty":50.989183,"marketCap":412828869},{"date":"2023-02-17","current":63.889078,"twenty":5.395729,"median":30.726752,"eighty":51.812419,"marketCap":400903963},{"date":"2023-02-24","current":58.549906,"twenty":5.423851,"median":30.872928,"eighty":52.172585,"marketCap":367400658},{"date":"2023-03-03","current":57.644961,"twenty":5.475409,"median":30.940583,"eighty":52.779722,"marketCap":361722131},{"date":"2023-03-10","current":56.106556,"twenty":5.507294,"median":31.026339,"eighty":52.96495,"marketCap":352068636},{"date":"2023-03-17","current":59.002378,"twenty":5.539642,"median":31.129245,"eighty":53.139887,"marketCap":370239921},{"date":"2023-03-24","current":61.08375,"twenty":5.565634,"median":31.256083,"eighty":53.407439,"marketCap":383300532},{"date":"2023-03-31","current":61.445728,"twenty":5.591919,"median":31.406014,"eighty":53.726443,"marketCap":385571942},{"date":"2023-04-06","current":61.08375,"twenty":5.638122,"median":31.503027,"eighty":53.89109,"marketCap":383300532},{"date":"2023-04-14","current":62.803145,"twenty":5.715788,"median":31.776429,"eighty":54.282127,"marketCap":394089732},{"date":"2023-04-21","current":56.016061,"twenty":5.800167,"median":31.94582,"eighty":55.571109,"marketCap":351500784},{"date":"2023-04-28","current":56.757062,"twenty":5.889576,"median":32.228692,"eighty":56.160852,"marketCap":356150561},{"date":"2023-05-05","current":24.731543,"twenty":6.039467,"median":32.415379,"eighty":56.342329,"marketCap":394641234},{"date":"2023-05-12","current":22.319588,"twenty":6.525956,"median":32.447324,"eighty":56.360184,"marketCap":356153661},{"date":"2023-05-19","current":21.995594,"twenty":6.590821,"median":32.447324,"eighty":56.360184,"marketCap":350983689},{"date":"2023-05-26","current":21.563602,"twenty":6.773144,"median":32.447324,"eighty":56.360184,"marketCap":344090392},{"date":"2023-06-01","current":21.419604,"twenty":6.793305,"median":32.447324,"eighty":56.360184,"marketCap":341792627},{"date":"2023-06-09","current":23.399568,"twenty":7.081692,"median":32.455526,"eighty":56.453844,"marketCap":373386903},{"date":"2023-06-16","current":22.823578,"twenty":7.191261,"median":32.455526,"eighty":56.453844,"marketCap":364195841},{"date":"2023-06-23","current":23.147572,"twenty":7.30346,"median":32.473165,"eighty":56.605453,"marketCap":369365813},{"date":"2023-06-30","current":23.975557,"twenty":7.332386,"median":32.537703,"eighty":56.681257,"marketCap":382577965},{"date":"2023-07-07","current":23.651563,"twenty":7.360874,"median":32.602241,"eighty":56.757062,"marketCap":377407993},{"date":"2023-07-14","current":21.707599,"twenty":7.488413,"median":32.608258,"eighty":56.771752,"marketCap":346388158},{"date":"2023-07-21","current":23.039574,"twenty":7.560291,"median":32.653799,"eighty":56.801131,"marketCap":367642489},{"date":"2023-07-28","current":24.900298,"twenty":17.199629,"median":32.693323,"eighty":56.815821,"marketCap":371089137},{"date":"2023-08-04","current":21.763998,"twenty":17.370024,"median":32.473165,"eighty":56.272572,"marketCap":324348859},{"date":"2023-08-11","current":23.230366,"twenty":17.370024,"median":32.261499,"eighty":55.997962,"marketCap":346202151},{"date":"2023-08-18","current":22.535771,"twenty":17.370024,"median":31.94582,"eighty":54.55997,"marketCap":335850591},{"date":"2023-08-25","current":22.034118,"twenty":17.370024,"median":31.802888,"eighty":54.096899,"marketCap":328374465},{"date":"2023-09-01","current":20.027509,"twenty":17.370024,"median":31.503027,"eighty":53.757314,"marketCap":298469960},{"date":"2023-09-08","current":17.635012,"twenty":17.239057,"median":31.414833,"eighty":53.448601,"marketCap":262814589},{"date":"2023-09-15","current":18.329608,"twenty":17.226892,"median":31.272741,"eighty":53.253082,"marketCap":273166149},{"date":"2023-09-22","current":17.210537,"twenty":16.940417,"median":31.137821,"eighty":52.995821,"marketCap":256488636},{"date":"2023-09-29","current":16.824651,"twenty":16.932962,"median":31.041743,"eighty":52.851754,"marketCap":250737770},{"date":"2023-10-06","current":17.210537,"twenty":16.732038,"median":30.974885,"eighty":52.316651,"marketCap":256488636},{"date":"2023-10-13","current":16.747473,"twenty":16.670296,"median":30.914301,"eighty":52.06968,"marketCap":249587597},{"date":"2023-10-20","current":16.631708,"twenty":16.608555,"median":30.837677,"eighty":51.246444,"marketCap":247862337},{"date":"2023-10-27","current":16.940417,"twenty":16.539095,"median":30.726752,"eighty":50.824536,"marketCap":252463030},{"date":"2023-11-02","current":16.863239,"twenty":16.11462,"median":30.60172,"eighty":50.454079,"marketCap":251312857},{"date":"2023-11-10","current":16.521509,"twenty":16.014289,"median":30.520167,"eighty":49.754329,"marketCap":194458156},{"date":"2023-11-17","current":16.521509,"twenty":16.014289,"median":30.468519,"eighty":44.73022,"marketCap":194458156},{"date":"2023-11-24","current":17.401352,"twenty":16.014289,"median":30.189254,"eighty":43.977661,"marketCap":204813916},{"date":"2023-12-01","current":18.183436,"twenty":16.014289,"median":30.039073,"eighty":43.860074,"marketCap":214019036},{"date":"2023-12-08","current":19.405441,"twenty":16.11462,"median":29.6371,"eighty":43.094886,"marketCap":228402036},{"date":"2023-12-15","current":18.818878,"twenty":16.014289,"median":29.535742,"eighty":42.820094,"marketCap":221498196},{"date":"2023-12-21","current":18.574477,"twenty":15.983418,"median":29.511352,"eighty":42.218766,"marketCap":218621596},{"date":"2023-12-27","current":19.796482,"twenty":15.967983,"median":29.362682,"eighty":42.119781,"marketCap":233004595},{"date":"2024-01-05","current":20.676326,"twenty":14.280594,"median":29.131142,"eighty":41.900534,"marketCap":243360355},{"date":"2024-01-12","current":19.16104,"twenty":14.280594,"median":29.033964,"eighty":41.266594,"marketCap":225525436},{"date":"2024-01-19","current":18.036795,"twenty":12.624076,"median":28.933904,"eighty":41.111092,"marketCap":212293076},{"date":"2024-01-26","current":18.525597,"twenty":14.280594,"median":28.73835,"eighty":40.950245,"marketCap":218046276},{"date":"2024-02-02","current":18.232316,"twenty":14.280594,"median":28.702365,"eighty":40.554867,"marketCap":214594356},{"date":"2024-02-09","current":93.335042,"twenty":14.280594,"median":28.628365,"eighty":40.422302,"marketCap":234177620},{"date":"2024-02-16","current":100.214775,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":251438870},{"date":"2024-02-23","current":99.297477,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":249137370},{"date":"2024-03-01","current":102.508019,"twenty":15.937112,"median":28.665848,"eighty":40.503967,"marketCap":257192620},{"date":"2024-03-08","current":87.601931,"twenty":15.937112,"median":28.665848,"eighty":40.589905,"marketCap":219793246},{"date":"2024-03-15","current":87.143283,"twenty":15.937112,"median":28.665848,"eighty":41.040631,"marketCap":218642496},{"date":"2024-03-22","current":89.665851,"twenty":15.937112,"median":28.665848,"eighty":41.2026,"marketCap":224971621},{"date":"2024-03-28","current":89.207202,"twenty":15.937112,"median":28.665848,"eighty":41.767019,"marketCap":223820871},{"date":"2024-04-05","current":112.827619,"twenty":14.280594,"median":28.628365,"eighty":42.195037,"marketCap":283084495},{"date":"2024-04-12","current":98.150855,"twenty":14.280594,"median":28.628365,"eighty":43.126328,"marketCap":246260495},{"date":"2024-04-19","current":113.974241,"twenty":14.280594,"median":28.628365,"eighty":43.954144,"marketCap":285961370},{"date":"2024-04-26","current":102.737344,"twenty":15.937112,"median":28.665848,"eighty":44.091139,"marketCap":257767995},{"date":"2024-05-03","current":108.555431,"twenty":15.937112,"median":28.665848,"eighty":49.033997,"marketCap":272365577},{"date":"2024-05-10","current":-59.638647,"twenty":7.636989,"median":28.55658,"eighty":49.908686,"marketCap":291573347},{"date":"2024-05-17","current":-66.423883,"twenty":7.498932,"median":28.385069,"eighty":49.908686,"marketCap":324746363},{"date":"2024-05-24","current":-58.448255,"twenty":7.393745,"median":28.282163,"eighty":49.908686,"marketCap":285753520},{"date":"2024-05-31","current":-59.638647,"twenty":7.332386,"median":28.178057,"eighty":49.908686,"marketCap":291573347},{"date":"2024-06-07","current":-74.637589,"twenty":7.30609,"median":28.024896,"eighty":49.908686,"marketCap":364903171},{"date":"2024-06-14","current":-77.375491,"twenty":7.19915,"median":27.948994,"eighty":49.918976,"marketCap":378288774},{"date":"2024-06-21","current":-71.125932,"twenty":7.118945,"median":27.784781,"eighty":49.929267,"marketCap":347734681},{"date":"2024-06-28","current":-69.161785,"twenty":7.043123,"median":27.699025,"eighty":49.960138,"marketCap":338131966},{"date":"2024-07-05","current":-63.80502,"twenty":6.810836,"median":27.600837,"eighty":49.960138,"marketCap":311942743},{"date":"2024-07-12","current":-69.042746,"twenty":6.637716,"median":27.435935,"eighty":49.960138,"marketCap":337549983},{"date":"2024-07-15","current":-70.471216,"twenty":6.635525,"median":27.384481,"eighty":49.960138,"marketCap":344533776},{"date":"2024-08-02","current":-30.086439,"twenty":6.577672,"median":27.104917,"eighty":50.433498,"marketCap":328754517},{"date":"2024-08-09","current":-28.326062,"twenty":6.484758,"median":26.909801,"eighty":50.433498,"marketCap":309518880},{"date":"2024-08-16","current":-27.579236,"twenty":5.966713,"median":26.576076,"eighty":50.433498,"marketCap":301358307},{"date":"2024-08-23","current":-28.272717,"twenty":5.88344,"median":26.426246,"eighty":50.433498,"marketCap":308935982},{"date":"2024-08-30","current":-27.845959,"twenty":5.768902,"median":26.340711,"eighty":50.433498,"marketCap":304272797},{"date":"2024-09-06","current":-27.099133,"twenty":5.715788,"median":26.332602,"eighty":50.433498,"marketCap":296112224},{"date":"2024-09-13","current":-26.61903,"twenty":5.655719,"median":26.295145,"eighty":50.433498,"marketCap":290866141},{"date":"2024-09-20","current":-24.805309,"twenty":5.58998,"median":26.295145,"eighty":50.433498,"marketCap":271047607},{"date":"2024-09-27","current":-25.285411,"twenty":5.563517,"median":26.295145,"eighty":50.433498,"marketCap":276293689},{"date":"2024-10-04","current":-24.005137,"twenty":5.528419,"median":26.295145,"eighty":50.433498,"marketCap":262304136},{"date":"2024-10-11","current":-23.525035,"twenty":5.491943,"median":26.295145,"eighty":50.433498,"marketCap":257058053},{"date":"2024-10-18","current":-25.258739,"twenty":5.461327,"median":26.295145,"eighty":50.433498,"marketCap":276002240},{"date":"2024-10-25","current":-24.111827,"twenty":5.418839,"median":26.295145,"eighty":50.433498,"marketCap":263469932},{"date":"2024-10-31","current":-24.325206,"twenty":5.391868,"median":26.014214,"eighty":50.433498,"marketCap":265801524},{"date":"2024-11-08","current":-17.855433,"twenty":5.367499,"median":26.015518,"eighty":50.454079,"marketCap":292614836},{"date":"2024-11-15","current":-18.145688,"twenty":5.359134,"median":26.015518,"eighty":50.454079,"marketCap":297371534},{"date":"2024-11-22","current":-17.576411,"twenty":5.328527,"median":26.015518,"eighty":50.454079,"marketCap":288042231},{"date":"2024-11-29","current":-18.323587,"twenty":5.313305,"median":26.015518,"eighty":50.454079,"marketCap":300286941},{"date":"2024-12-06","current":-17.007135,"twenty":5.288291,"median":26.015518,"eighty":50.454079,"marketCap":278712928},{"date":"2024-12-13","current":-16.437858,"twenty":5.274959,"median":26.015518,"eighty":50.454079,"marketCap":269383625},{"date":"2024-12-20","current":-16.473438,"twenty":5.247835,"median":26.015518,"eighty":50.454079,"marketCap":269966706},{"date":"2024-12-27","current":-17.113874,"twenty":5.219777,"median":26.015518,"eighty":50.454079,"marketCap":280462172},{"date":"2025-01-03","current":-17.149454,"twenty":5.200137,"median":26.015518,"eighty":50.454079,"marketCap":281045254},{"date":"2025-01-10","current":-16.544598,"twenty":5.172047,"median":26.048037,"eighty":50.47466,"marketCap":271132869},{"date":"2025-01-17","current":-15.797422,"twenty":5.151955,"median":26.048037,"eighty":50.47466,"marketCap":258888159},{"date":"2025-01-24","current":-15.726263,"twenty":5.141617,"median":26.048037,"eighty":50.47466,"marketCap":257721996},{"date":"2025-01-31","current":-16.295539,"twenty":5.116334,"median":26.048037,"eighty":50.47466,"marketCap":267051299},{"date":"2025-02-07","current":-16.686917,"twenty":5.087903,"median":26.048037,"eighty":50.47466,"marketCap":273465195},{"date":"2025-02-14","current":-14.499909,"twenty":5.060621,"median":26.048037,"eighty":50.47466,"marketCap":274048276},{"date":"2025-02-21","current":-13.853917,"twenty":5.016797,"median":26.048037,"eighty":50.47466,"marketCap":261839037},{"date":"2025-02-28","current":-14.501873,"twenty":4.989699,"median":26.048037,"eighty":50.47466,"marketCap":274085406},{"date":"2025-03-07","current":-15.149829,"twenty":4.942936,"median":26.113076,"eighty":50.47466,"marketCap":286331776},{"date":"2025-03-14","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-21","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-28","current":-14.193323,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":268253802},{"date":"2025-04-04","current":-13.483657,"twenty":4.939984,"median":26.113076,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-11","current":-12.58886,"twenty":4.887176,"median":26.048037,"eighty":50.47466,"marketCap":237929459},{"date":"2025-04-17","current":-13.483657,"twenty":4.834368,"median":26.048037,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-25","current":-13.298526,"twenty":4.763966,"median":26.113076,"eighty":50.47466,"marketCap":251342149},{"date":"2025-05-02","current":-13.844808,"twenty":4.709103,"median":26.113076,"eighty":50.47466,"marketCap":261666880},{"date":"2025-05-09","current":-5.620625,"twenty":4.634656,"median":26.113076,"eighty":50.47466,"marketCap":248701404},{"date":"2025-05-16","current":-5.234418,"twenty":4.508876,"median":26.113076,"eighty":50.47466,"marketCap":231612514},{"date":"2025-05-19","current":-5.540758,"twenty":4.491594,"median":26.113076,"eighty":50.47466,"marketCap":245167445}],"updateTime":1747810106641}}}